Denial Management Best Practices That Work

Claim denials are often treated as a billing problem.

That makes sense at first. Billing teams usually see the denial first. They correct the claim, prepare the appeal, contact the payer, and track the lost revenue.

But many denials do not start in billing.

They start when insurance is not verified, documentation is incomplete, prior authorization is missed, payer rules are not checked, or an order reaches the billing team with missing information.

For diagnostic labs, this problem is even more specific. Many denials begin at the order or requisition stage, before the claim exists. A missing diagnosis code, incomplete provider information, frequency limit issue, ABN gap, or payer-specific coverage rule can create revenue leakage long before the claim reaches the payer.

That is why denial management best practice is not only about appealing denied claims faster. It is about moving from claim cleanup to claim risk control.

A strong denial management process helps healthcare organizations answer five questions:

• Why was the claim denied?
• Where did the issue begin?
• Who owns the fix?
• How can the team prevent the same denial next time?
• What data proves the process is improving?

What Is Denial Management Best Practice?

Denial management best practice is the process of identifying, correcting, appealing, tracking, and preventing claim denials.

But the strongest programs go beyond denial cleanup.

They use denial data to improve the full revenue cycle. They do not only ask, “How do we get this claim paid?” They also ask, “What workflow allowed this denial to happen?”

HFMA reports that denials can be created or prevented across many points of the revenue cycle, including scheduling, insurance verification, financial clearance, clinical documentation, claim processing, and denial resolution. This matters because denial management is not one department’s job.

AHIMA also notes the need for a structured approach to claims denial resolution, including denial analysis, documentation review, and root-cause resolution.

For healthcare organizations, denial management best practice has three layers:

1. Teams need to resolve current denials.

2. They need to identify root causes.

3. They need to change the workflow that created the denial.

Without the third step, denial management becomes expensive rework.

Why Lab Denials Need a Different Management Model

Diagnostic labs need a more specific denial management model because many lab denials are not pure billing failures.

They may be order-quality failures.

They may be payer-policy failures.

They may be documentation-timing failures.

They may be provider-communication failures.

This distinction matters for lab owners. If every denial is treated as a billing issue, the lab may keep fixing claims after rejection without improving the process that created the risk.

For example, a lab may receive a denial because the diagnosis code does not support the ordered test. The billing team sees the denial, but the root cause may be an incomplete requisition, unclear provider documentation, or a payer rule that should have been checked earlier.

A lab may also receive repeated denials for small-dollar claims. One claim may not look urgent. But if the same denial appears across high-volume tests, one payer, or one ordering provider, it becomes a larger revenue problem.

That is why labs should think beyond the post-denial queue.

They also need a pre-billing risk queue.

This is a workflow where claims are held for review before submission when they have missing or risky information, such as:

• Missing diagnosis information
• Missing provider details
• Missing insurance data
• Possible frequency limit issue
• Possible ABN requirement
• ICD-test mismatch
• Missing supporting documentation
• Payer-specific policy conflict

The best lab denial queue is the one that exists before the payer ever sees the claim.

Lab owners should also measure denial prevention yield. This means tracking how many risky claims were corrected before submission, not only how many claims were denied after submission.

Useful prevention metrics may include:

• Claims held for clarification
• Missing fields resolved before billing
• Provider clarifications received
• ABNs collected before service when applicable
• Claims corrected after payer-rule review
• Claims released after documentation review

A lab should not only measure denied claims. It should measure how many denials were prevented before submission.

10 Best Practices in Denial Management

1. Track Denials by Root Cause, Not Only Denial Code

Denial codes are useful, but they rarely tell the full story.

A payer code may say the claim was denied for medical necessity, missing information, eligibility, prior authorization, or duplicate billing. But that does not always show where the internal process failed.

For example, a medical necessity denial may come from an unsupported diagnosis code, missing clinical documentation, an outdated payer rule, or an order that needed provider clarification before submission.

HFMA’s denial metrics guidance supports the need for consistent denial categories and standard measurement. Without standard tracking, organizations cannot compare denial trends or know whether improvement efforts are working.

A strong denial tracking system should include:

• Denial reason
• Payer
• Claim value
• Service, procedure, or test category
• Department or location
• Provider or ordering source
• Appeal outcome
• Days in denial
• Preventability
• Workflow owner

For hospitals, root-cause tracking may show that certain departments create more prior authorization or documentation denials.

For physician practices, it may reveal eligibility errors, referral gaps, or recurring coding issues.

For diagnostic labs, root-cause tracking should be more specific. Labs should track denials by ordering provider, test category, payer, missing requisition field, ICD-test mismatch, frequency limit issue, ABN issue, and documentation gap.

This helps lab leaders see whether denials are isolated payer events or repeatable workflow problems.

2. Move Eligibility and Coverage Checks Earlier

Eligibility and coverage checks are basic, but they are still a major source of avoidable denials.

A patient may have active insurance, but that does not always mean the service is covered. A payer may require prior authorization. A plan may limit how often a service can be performed. A test may be covered only for certain diagnoses. A payer may need specific documentation before payment.

MGMA highlights revenue cycle leakage in medical practices, including denials, front-end errors, billing challenges, and coding inefficiencies. Its guidance also points to the importance of front-end KPIs, such as eligibility error rates and avoidable reschedules tied to authorization delays.

The AMA has also reported that prior authorization creates major administrative pressure for physicians and can delay care. For revenue cycle teams, this means authorization cannot be treated as a last-minute task.

The best practice is to move eligibility, benefits, and coverage checks closer to the start of the workflow.

For hospitals, this means validating coverage and authorization before scheduled procedures, high-cost services, imaging, and inpatient or outpatient care.

For physician practices, this means confirming insurance, referrals, plan changes, and authorization requirements before the visit whenever possible.

For diagnostic labs, this means checking payer requirements before billing, especially for tests with strict coverage rules, frequency limits, or documentation requirements.

Labs may not control every part of the ordering workflow. But they can still improve intake checks, payer-rule review, and provider communication before a denial reaches billing.

3. Treat Order and Documentation Quality as Denial Metrics

Documentation quality is one of the most important denial prevention areas.

AHIMA’s denial resolution guidance shows that documentation review is central to resolving claim issues. AAPC also explains that NCDs and LCDs help determine which diagnosis codes must be documented to support medical necessity for services or supplies.

For hospitals, documentation quality may involve admission status, level of care, procedure notes, discharge details, or clinical justification for high-cost services.

For physician practices, it may involve diagnosis support, procedure documentation, modifier use, referral records, and prior authorization notes.

For diagnostic labs, documentation quality often starts with the requisition.

A lab requisition is not just an order form. It is also a revenue cycle document, a compliance document, and a communication bridge between the ordering provider, lab, billing team, and payer.

Labs should measure requisition quality as part of denial management.

Important requisition checks include:

• Complete patient demographics
• Accurate insurance information
• Ordering provider details
• Ordered tests
• Diagnosis codes
• Provider signature when required
• Date of order
• Specimen details
• Required clinical context
• Supporting documentation when needed

If a lab waits until denial to fix missing requisition details, the process is already too late.

A stronger workflow flags missing or risky information during intake or pre-billing review. This does not mean the lab makes clinical decisions for the provider. It means the lab supports a cleaner billing and compliance process by requesting clarification and documenting communication.

For high-volume labs, small documentation errors can create large revenue leakage when repeated across many claims.

4. Validate Payer Rules Before Submission

A clean claim is not only complete. It also has to match payer rules.

This is where denial management becomes more complex.

CMS explains that ICD-10-CM codes are used in Medicare billing claims for diagnostic clinical laboratory services. CMS also maintains lab NCD resources and the Medicare Coverage Database, where organizations can search coverage documents by keyword, code, or document ID.

For labs, this matters because some tests are affected by National Coverage Determinations, Local Coverage Determinations, billing articles, ICD-10 coding rules, and payer-specific documentation requirements.

CMS also states that an Advance Beneficiary Notice of Noncoverage, or ABN, may be issued by providers, including independent laboratories, when Medicare payment is expected to be denied. Noridian Medicare guidance adds that an ABN is a standardized notice that should be given before certain Medicare items or services are provided.

Payer-rule validation should include:

• Is the service covered under the payer’s policy?
• Is prior authorization required?
• Does the diagnosis code support the service or test?
• Is there a frequency limit?
• Is there a duplicate testing risk?
• Is an ABN needed for Medicare fee-for-service when payment is expected to be denied?
• Is supporting documentation available if the payer requests it?

For diagnostic labs, payer validation should not be only a post-denial activity. It should be part of a pre-submission workflow that checks whether the claim has enough support before it reaches the payer.

Medical necessity is one part of this larger process. A lab may also need a dedicated workflow for avoiding medical necessity denials with AI, but that should sit inside a broader denial management program that also covers eligibility, documentation, frequency limits, ABNs, payer policy changes, and claim edits.

The provider remains responsible for clinical judgment and ICD-code selection. The lab’s role is to support the process by flagging risks, requesting clarification, and maintaining audit-ready documentation.

5. Assign Ownership by Denial Type

Denials often stay unresolved because ownership is unclear.

A claim may move between billing, coding, compliance, intake, provider relations, and payer follow-up. Each team may see only part of the issue.

Strong denial management requires clear ownership.

Eligibility denials may point to registration, intake, or insurance verification.

Prior authorization denials may point to scheduling, authorization, or referral workflows.

Coding denials may point to coding review or provider documentation.

Documentation denials may require clinical, provider, or ordering-source follow-up.

Medical necessity denials may involve coding, payer-policy review, compliance review, and provider clarification.

Timely filing denials may require workflow review across documentation collection, claim edits, and submission processes.

For diagnostic labs, ownership can be more complex because the lab often depends on outside ordering providers.

That means provider communication must be part of denial management.

Labs should define who owns:

• Requesting missing requisition information
• Contacting ordering providers
• Reviewing payer-specific requirements
• Flagging frequency limit risk
• Managing ABN workflows
• Collecting supporting documentation
• Appealing denied claims
• Feeding denial trends back into operations

Without ownership, labs may keep absorbing denials that could have been prevented during intake or provider communication.

6. Build a Feedback Loop Between Billing, Compliance, and Operations

Denial management should not end when a claim is appealed.

Every preventable denial should create a workflow question.

What made this denial possible?

Was the payer rule missed? Was the requisition incomplete? Was documentation requested too late? Did the ordering provider need clearer instructions? Did the claim edit appear after the best correction point? Did the payer change a rule that the team did not catch?

This feedback loop is where many denial management programs fall short. They resolve the claim but do not fix the process.

A strong feedback loop includes:

• Monthly denial trend reviews
• Denial reporting by payer, provider, department, and service type
• Escalation paths for repeat denial patterns
• Updates to intake or front-end workflows
• Provider education when documentation gaps repeat
• Payer-rule monitoring
• Requisition or order form improvements
• Compliance review for high-risk patterns

For labs, this can create real operational value.

If one payer repeatedly denies a test category, the lab may need stronger payer validation.

If one ordering provider often submits incomplete requisitions, the lab may need better provider communication.

If frequency limit denials are increasing, the lab may need a pre-billing review step for repeat tests.

If ABN-related denials are common, the lab may need to review whether ABN workflows are clear, timely, and documented.

This is how denial data becomes prevention data.

7. Prioritize Denials by Revenue Risk and Prevention Value

Not every denial should be worked the same way.

Some denials are high-dollar and need fast escalation. Others are lower-dollar but repeat so often that they create major revenue leakage. Some are easy to overturn. Others cost more to appeal than they are worth.

Best practice means prioritizing denials by both revenue risk and prevention value.

Teams should consider:

• Claim value
• Payer
• Denial reason
• Appeal deadline
• Likelihood of recovery
• Cost to appeal
• Repeat frequency
• Whether the denial reveals a preventable workflow issue

For hospitals, this may mean prioritizing high-dollar inpatient, surgical, or specialty service denials.

For physician practices, it may mean focusing on recurring eligibility, referral, modifier, or authorization issues.

For diagnostic labs, the calculation is different.

A single denied lab claim may not look large compared with a hospital claim. But repeated denials across high-volume tests can create serious revenue loss.

Lab leaders should watch denial patterns across common test panels, specific payers, ordering providers, diagnosis code patterns, missing requisition fields, frequency limits, ABN workflows, and documentation requests.

The best question is not only, “Is this claim worth appealing?”

It is also, “Could fixing this issue prevent hundreds of similar denials?”

8. Use Automation and AI as a Review Layer

Automation and AI can support denial management, but they should not replace expert review.

AI should not be framed as replacing providers, coders, billers, or compliance teams. It should support these teams by helping them find risks earlier, organize documentation faster, and reduce manual review burden.

In denial management, automation and AI can help with:

• Missing-field detection
• Eligibility and coverage workflow support
• Payer-rule review
• Claim edit prioritization
• Denial pattern analysis
• Documentation gap detection
• Appeal workflow support
• Provider communication prompts
• Structured medical necessity justification for review

For diagnostic labs, AI can be useful before submission. It can help teams review requisitions, flag missing information, support ICD-test validation, identify payer-specific compliance risks, and organize documentation for review.

But AI should sit inside a governed workflow.

Providers remain responsible for clinical judgment and ICD-code selection. Billing and compliance teams remain responsible for review, escalation, and final decisions.

For diagnostic labs, Docus supports this prevention-first model through solutions such as AI Compliance Agent and AI-Powered Requisitions. These tools can help teams flag payer-specific compliance risks, identify documentation gaps, and structure medical necessity justification for review. They do not replace provider judgment, billing expertise, or compliance review. They help labs catch risks earlier, before preventable issues become denied claims.

9. Track KPIs That Show Prevention, Not Just Recovery

Many organizations track denial volume. Fewer track whether denial management is actually improving.

HFMA’s work on standardizing denial metrics supports the need for standard measurement, benchmarking, and process improvement. This matters because teams cannot improve what they define inconsistently.

A useful KPI set should show both back-end recovery and upstream prevention.

Core denial management KPIs include:

• Denial rate
• Clean claim rate
• First-pass resolution rate
• Appeal success rate
• Days in denial
• Net collection rate
• Write-off rate
• Denial overturn rate
• Avoidable denial rate
• Denials by payer
• Denials by provider
• Denials by department, location, service, or test category

For diagnostic labs, additional KPIs may be more useful:

• Requisition error rate
• Missing diagnosis code rate
• Missing provider information rate
• Missing insurance information rate
• Medical necessity denial rate
• Frequency limit denial rate
• ABN-related denial rate
• Denials by ordering provider
• Denials by test category
• Denials by payer policy issue
• Claims held for clarification before submission
• Denial prevention yield

These KPIs help lab leaders see denial prevention as an operational discipline, not only a billing function.

A rising number of claims held for clarification may look like friction at first. But if it reduces downstream denials, it may show that the lab is catching problems earlier.

That is the kind of metric shift mature organizations need.

10. Make Denial Management Cross-Functional

The most effective denial management programs are not owned by billing alone.

Billing sees the denial, but billing may not control the root cause.

A denial may involve registration, scheduling, provider documentation, ordering workflows, coding, compliance, payer rules, claim edits, or patient communication.

That is why denial management should involve cross-functional leadership.

A strong denial management team may include:

• Billing leaders
• Coding specialists
• Compliance staff
• Operations leaders
• Front-end or intake teams
• Provider relations teams
• Clinical documentation specialists
• IT or automation teams
• Finance leaders

For diagnostic labs, provider relations should also be part of the process.

Ordering providers influence requisition quality, diagnosis information, documentation support, and test ordering patterns. If labs only fix denials internally, they may miss the external workflow problems that keep creating them.

The goal is not to blame one team.

The goal is to create a shared system where each denial type has a clear owner, a measurable pattern, and a prevention plan.

Common Mistakes That Keep Denial Rates High

Even experienced healthcare organizations struggle with denial management when the process is too narrow.

Common mistakes include treating denials as a billing-only issue. Billing may resolve the claim, but the root cause may live upstream.

Another mistake is tracking denial codes without tracking internal workflow causes. This limits prevention.

Some teams focus only on high-dollar denials. That can be risky for labs, where repeated lower-dollar denials across high-volume tests can create major revenue leakage.

Another common mistake is appealing claims without changing the process. This creates recurring rework.

Many organizations also review payer rules only after denial. By then, the claim may already be harder and more expensive to recover.

Some teams underuse denial data. Denial reports should guide training, payer-rule updates, requisition changes, and provider communication.

Finally, some organizations use automation without governance. AI should support expert review, not replace it.

For lab leaders, the biggest mistake is waiting until billing to manage problems that started at order intake.